Latest Trials

EudraCT Number: 2004-004482-15 Sponsor Protocol Number: NRA 1280013 Start Date:
Sponsor Name: Universitätsklinikum Aachen, Klinik f. Psychiatrie und Psychotherapie
Full Title: Hirnaktivierung während Gedächtnisaufgaben bei Patienten mit Schizophrenie unter Behandlung von Ziprasidon oder Risperidon. Eine FMRT-Untersuchung.
Medical condition: Patienten mit DSM-IVTR diagnostizierter Schizophrenie
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2007-000627-17 Sponsor Protocol Number: PAR007 Start Date:
Sponsor Name: University of Iceland
Full Title: Serum profiles of paracetamol and glutathione after high doses of paracetamol for 6 days
Medical condition: Healthy volunteers
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: IS (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2008-008306-43 Sponsor Protocol Number: NN1250-1995 Start Date:
Sponsor Name: Novo Nordisk A/S
Full Title: A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 Diabetes
Medical condition: Type I diabetes mellitus
Disease: Version SOC Term Classification Code Term Level
12.0 10045228 Type I diabetes mellitus LLT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2007-004150-85 Sponsor Protocol Number: HINEF: PDE5 Start Date:
Sponsor Name: Charité Universitaetsmedizin Berlin
Full Title: Cardiac failure with normal ejection fraction: possible role of phosphodiesterase type 5 inhibitors
Medical condition: Patients with cradiac failure and normal ejection fraction
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-004798-60 Sponsor Protocol Number: CL3-00780-148 Start Date:
Sponsor Name: I.R.I.S. Institut de Recherches Internationales Servier
Full Title: A one-year multicentre, international, randomised, double-blind study with comparison of benfluorex (150 mg od to 150 mg tid) versus pioglitazone (30 mg od to 45 mg od) in combination with sulfonyl...
Medical condition: Type II Diabetes
Disease: Version SOC Term Classification Code Term Level
7.0 10012613 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2014-001978-33 Sponsor Protocol Number: 150400 Start Date:
Sponsor Name: Brighton and Sussex University Hospitals NHS Trust
Full Title: How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children?
Medical condition: Recurrent wheeze in preschool children
Disease: Version SOC Term Classification Code Term Level
19.0 100000004855 10047921 Wheeze LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2013-003303-18 Sponsor Protocol Number: rl.01.2013 Start Date:
Sponsor Name: Gedeon Richter Polska Sp. z o. o.
Full Title: Clinical phase IV study assessing the efficacy and safety of the medicinal product Groprinosin in treatment of recurrent airway inflammation in children with impaired cellular immunity and diagnose...
Medical condition: Recurrent airway inflammation in children with impaired cellular immunity.
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: PL (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2016-003679-23 Sponsor Protocol Number: EPITOPE-V712-304 Start Date:
Sponsor Name: DBV TECHNOLOGIES S.A.
Full Title: A double-blind, placebo-controlled, randomized phase III trial to assess the safety and efficacy of Viaskin® Peanut in peanut-allergic young children 1-3 years of age (EPITOPE study)
Medical condition: Peanut allergy
Disease: Version SOC Term Classification Code Term Level
20.1 100000004870 10034202 Peanut allergy LLT
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: IE (Completed) FR (Ongoing) DE (Completed) NL (Completed)
Trial results: (No results available)
EudraCT Number: 2018-003713-18 Sponsor Protocol Number: INCB18424-304 Start Date:
Sponsor Name: Incyte Corporation
Full Title: A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long Term Safety Extension Period in Adolescents and Adults With Atopic ...
Medical condition: Atopic dermatitis
Disease: Version SOC Term Classification Code Term Level
21.1 100000004858 10003639 Atopic dermatitis LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) DE (Completed) BG (Completed) PL (Completed) ES (Completed)
Trial results: (No results available)
EudraCT Number: 2021-000085-14 Sponsor Protocol Number: D3258C00001 Start Date:
Sponsor Name: AstraZeneca AB
Full Title: A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled 3-Part Phase 3 Study to Demonstrate the Efficacy and Safety of Benralizumab in Patients with Eosinophilic Gastritis and/...
Medical condition: Eosinophilic Gastritis and/or Gastroenteritis
Disease: Version SOC Term Classification Code Term Level
23.0 10017947 - Gastrointestinal disorders 10083619 Eosinophilic gastritis PT
20.1 10017947 - Gastrointestinal disorders 10017902 Gastroenteritis eosinophilic PT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended) ES (Ongoing) NL (Completed) PL (Completed) IT (Ongoing) FR (Completed) BE (Completed)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe